Programmed nanoparticle-loaded microparticles for effective antigen/adjuvant delivery

Rong Xu,Ying Dong,Yajing Zhang,Xiaoli Wang,Chuangnian Zhang,Yanjun Jiang

DOI: https://doi.org/10.1016/j.partic.2021.02.007

IF: 3.5

2022-01-01

Particuology

Abstract:<p>A microscale vaccine that SiO₂ nanoparticles-loaded in CaCO₃ microparticles was constructed through the co-precipitation method, the antigen was covalently conjugated with SiO₂ nanoparticles, then these nanoparticles and CpG were co-encapsulated into CaCO₃ microparticles, generating the vaccine with a size of approximately 5.2 μm. SEM, EDX, element mapping, and FTIR confirmed the successful preparation of microscale vaccine, which had good storage stability without the sustained release of antigen, and negligible cytotoxicity to dendritic cells (DCs) and macrophages. Compared to SiO₂ nanoparticles, the microscale vaccine can significantly improve the antigen/adjuvant uptake. DCs internalized the entire microscale vaccine into lysosome via macropinocytosis, and an increase in antigen endo/lysosomal escape was observed by CLSM. Specifically, DCs pulsed by the vaccine was fully mature, not only expressing high levels of costimulatory molecules (CD40, CD80, CD86), MHC II and MHC I, but also secreting high levels of pro-inflammatory cytokines (IL-12, TNF-α, IL-1β and IL-6). Besides, the vaccine had good <em>in vivo</em> biocompatibility, can protect the antigen from rapid degradation, and increase the retention time in lymph nodes (LNs). SiO₂ nanoparticles-in-CaCO₃ microparticles was an excellent carrier of antigen/adjuvant delivery. Hopefully, this work can provide some information on the design of microscale carrier for vaccine delivery system.</p>

materials science, multidisciplinary,engineering, chemical

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to effectively improve the delivery efficiency of antigens and adjuvants in the vaccine delivery system while enhancing the immune response. Specifically, the researchers constructed a new nanoparticle - in - microparticle (NPs - in - MP) structure and prepared calcium carbonate microparticles (CaCO_3 MPs) loaded with silica nanoparticles (SiO_2 NPs) by the coprecipitation method for the effective delivery of antigens and adjuvants. This structure aims to:

1. **Improve the uptake efficiency of antigens and adjuvants**: By covalently binding the antigen to SiO_2 NPs and co - encapsulating these NPs and the adjuvant CpG in CaCO_3 MPs to form a vaccine. Studies have shown that this micro - vaccine can be efficiently taken up by dendritic cells (DCs) through macropinocytosis, thereby significantly improving the uptake efficiency of antigens and adjuvants.

2. **Promote the lysosomal escape of antigens**: The experimental results show that after using this micro - vaccine, the antigen can escape from endosomes/lysosomes, which helps to enhance the antigen - presentation efficiency and further activate DCs.

3. **Enhance the maturity of DCs**: DCs after vaccination show high expression of co - stimulatory molecules (such as CD40, CD80, CD86), MHC I and MHC II, and secrete high - level pro - inflammatory cytokines (such as IL - 12, TNF - α, IL - 1β and IL - 6), indicating that DCs are fully activated.

4. **Improve in - vivo biocompatibility and protect antigens from rapid degradation**: This vaccine has good biocompatibility, can protect antigens from rapid degradation, and increase their retention time in lymph nodes, thereby prolonging the duration of the immune response.

In summary, this paper aims to solve the problems of low uptake efficiency of antigens and adjuvants and weak immune responses in existing vaccine delivery systems by designing a new NPs - in - MP structure, providing new ideas and methods for the design of tumor vaccines.